Industry

DUBLIN–(BUSINESS WIRE)–The “Global Orphan Diseases Partnering 2010-2022: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. The Global Orphan Diseases Partnering 2010-2022 report provides comprehensive access to available deals and contract documents for over 280 orphan diseases deals signed between the world’s pharmaceutical and biotechnology companies since 2010. Trends in Orphan Diseases … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Biologic Therapies for Wound Care: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. This report studies the global market for wound care biologics. It describes different types of wound care biologics, including cellular and/or tissue-based products (CTPs), skin substitutes and topical agents, and their current and historical market revenues. Wound … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022” report has been added to ResearchAndMarkets.com’s offering. The Cancer Monoclonal Antibody Partnering Terms & Agreements report provides comprehensive access to available deals and contract documents for over 600 cancer monoclonal antibody deals entered into by the worlds leading healthcare companies. This report provides details … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2014-2022: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmics Partnering 2014-2022 report provides comprehensive access to available deals and contract documents for over 550 ophthalmics deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Ophthalmics partnering deals Financial deal … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “2021 Healthcare Research Review” report has been added to ResearchAndMarkets.com’s offering. This Research Review is a collection of highlights from several healthcare market research reports that were published in 2019. This review was compiled with an intent of providing a sampling of the type of market information, guidance, and analysis, that have been … [Read more…]

CAMBRIDGE, England–(BUSINESS WIRE)–EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect. Colin’s appointment will support the next phase of the Company’s development and the commercialisation of its semiconductor-based DNA synthesis platform. Colin brings over 20 years’ experience … [Read more…]

Dr Leroy will oversee the pipeline of the company in immuno-oncology and will be responsible for advancing the GPCR programs to the clinic STRASBOURG, France & MONTREAL, Canada–(BUSINESS WIRE)–Domain Therapeutics, a biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology (IO), today announced that it is … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) – also known as Johne’s disease, that could save the New Zealand dairy industry upwards of $80 million a year in lost production. “The PictArray™ MAP assay would be a positive addition to national … [Read more…]

This year’s Diabetes Awareness Week (13-19 June) is celebrating the triumphs and challenges for all people with diabetes. To celebrate the week, as well as the updated NICE (National Institute of Health and Care Excellence) guidelines, which will allow more people than ever before have access to modern diabetes management technology, Dexcom is hosting its … [Read more…]

SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News: Median Technologies (ALMDT) announces today the publication of an initiation report by Bryan Garnier & Co, a pan-European investment bank focusing on growth companies. In the initiation report published on June 10, 2022, Bryan Garnier & Co initiates the coverage of the stock with a buy recommendation and values the … [Read more…]